首页> 外文期刊>International journal of oncology >Differential expression of miRNAs in colon cancer between African and Caucasian Americans: Implications for cancer racial health disparities
【24h】

Differential expression of miRNAs in colon cancer between African and Caucasian Americans: Implications for cancer racial health disparities

机译:非洲裔美国人与高加索人之间结肠癌中miRNA的差异表达:对癌症种族健康差异的影响

获取原文

摘要

Colorectal cancer (CRC) incidence and mortality are higher in African Americans (AAs) than in Caucasian Americans (CAs) and microRNAs (miRNAs) have been found to be dysregulated in colonic and other neoplasias. The aim of this exploratory study was to identify candidate miRNAs that could contribute to potential biological differences between AA and CA colon cancers. Total RNA was isolated from tumor and paired adjacent normal colon tissue from 30?AA and 31?CA colon cancer patients archived at Stony Brook University?(SBU) and Washington University?(WU)?St.?Louis Medical Center. miRNA profiles were determined by probing human genome-wide miRNA arrays with RNA isolated from each sample. Using repeated measures analysis of variance?(RANOVA), miRNAs were selected that exhibited significant (p1.5, p<0.05) main effects of race and/or tumor. Quantitative polymerase chain reaction?(q-PCR) was used to confirm miRNAs identified by microarray analysis. Candidate miRNA targets were analyzed using immunohistochemistry. RANOVA results indicated that miR-182, miR152, miR-204, miR-222 and miR-202 exhibited significant race and tumor main effects. Of these miRNAs, q-PCR analysis confirmed that miR-182 was upregulated in AA vs. CA tumors and exhibited significant race:tumor interaction. Immunohistochemical analysis revealed that the levels of FOXO1 and FOXO3A, two potential miR-182 targets, are reduced in AA?tumors. miRNAs may play a role in the differences between AA and CA colon cancer. Specifically, differences in miRNA expression levels of miR-182 may contribute to decreased survival in AA colon cancer patients.
机译:非裔美国人(AAs)的大肠癌(CRC)发病率和死亡率高于高加索美国人(CAs),并且发现microRNA(miRNA)在结肠癌和其他瘤形成中失调。这项探索性研究的目的是鉴定可能导致AA和CA结肠癌之间潜在生物学差异的候选miRNA。从肿瘤中分离出总RNA,并从Stony Brook University(SBU)和Washington University(WU)?St.Louis Medical Center存档的30?AA和31?CA结肠癌患者的配对的正常结肠组织中配对。通过用从每个样品中分离的RNA探查人类全基因组miRNA阵列来确定miRNA谱。使用重复测量方差分析(RANOVA),选择显示出种族和/或肿瘤显着(p1.5,p <0.05)主要效应的miRNA。定量聚合酶链反应(q-PCR)被用于确认通过微阵列分析鉴定的miRNA。使用免疫组织化学分析候选miRNA靶标。 RANOVA结果表明miR-182,miR152,miR-204,miR-222和miR-202表现出显着的种族和肿瘤主要作用。在这些miRNA中,q-PCR分析证实,miR-182在AA与CA肿瘤中上调,并表现出显着的种族:肿瘤相互作用。免疫组织化学分析显示,AA肿瘤中两个潜在的miR-182靶标FOXO1和FOXO3A的水平降低。 miRNA可能在AA和CA结肠癌之间的差异中发挥作用。具体而言,miR-182的miRNA表达水平的差异可能会导致AA结肠癌患者的生存期降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号